FRG announces new molecular imaging division

NewsGuard 100/100 Score

Foundation Radiology Group (FRG), a premier provider of diagnostic imaging professional services, headquartered in downtown Pittsburgh, is pleased to announce its new division, FRG Molecular Imaging, which will be led by nationally renowned physician and PET/CT imaging pioneer, Todd M. Blodgett, M.D..

Prior to working with FRG Molecular Imaging, Dr. Blodgett served as the Chief of Cancer Imaging at the University of Pittsburgh Medical Center's Hillman Cancer Center and the owner of Blodgett Consulting, LLC, a PET/CT consulting group.

FRG Molecular Imaging will specialize in high-quality PET/CT interpretations, with additional services including over-read services, peer review, technologist training, protocol optimization, and online access to patient's images. In addition, FRG Molecular Imaging will be able to offer its clients a set of unique educational tools for interpreting physicians, referring physicians and other personnel involved in PET/CT imaging.

Dr. Blodgett holds a Bachelor of Science in Neuroscience from the University of Pittsburgh. He received his M.D. from the University of Pittsburgh, and also completed two Fellowships, one in PET & PET/CT and another in Oncologic Imaging through the University of Pittsburgh Medical Center (UPMC). Dr. Blodgett currently serves as Assistant Professor of Radiology at UPMC.

"Dr. Blodgett is highly respected in the radiology community, and truly is a pioneer in the PET/CT field. We are extremely pleased to have him join the FRG team." said Dr. James Backstrom, Chief Medical Officer, FRG. "FRG Molecular Imaging will allow us to offer the highest possible quality PET/CT interpretations to the patients within our network."

"It's a pleasure to become part of such an incredibly talented team," said Blodgett. "The landscape of radiology as we know it is changing, and FRG is successfully leading the charge for advances in technology and positive impacts on patient care for all of the hospitals within its network."

SOURCE Foundation Radiology Group

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Revolutionizing brain tumor treatment: the rise of AI in neuro-oncology